학술논문
Cost-effectiveness of alectinib compared to crizotinib for the treatment of first-line ALK+ advanced non-small-cell lung cancer in France
Document Type
Article
Author
Source
In: PLoS ONE . (PLoS ONE, 1 January 2020, 15(1))
Subject
Language
English
ISSN
19326203